Navigation Links
Drug Reduces Airway Mucus in Preclinical Asthma Model
Date:2/19/2008

SAN FRANCISCO, Feb. 19 /PRNewswire/ -- Inverseon, Inc. (http://www.inverseon.com) announces the publication of a rapid communication of groundbreaking research led by Professor Richard Bond of the University of Houston, Inverseon's Scientific Founder. In the March article by Nguyen, et. al., in the American Journal of Respiratory Cell and Molecular Biology 2008; 38: 256-262, entitled, "Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model," airway mucus hypersecretion and inflammation were almost completely reversed upon treatment with certain beta blockers. The Journal commented that, "This research may result in a paradigm shift in the treatment of asthma. This research demonstrates the importance that duration of therapy has on clinical and physiologic responses."

"It is gratifying to see these findings, which were originally described in Prof. Bond's laboratory, confirmed in a respected independent laboratory," commented William J. Garner, MD, Chairman of Inverseon.

About Inverseon, Inc.

Inverseon's product development programs target significant unmet medical needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded based on the original work of Prof. Richard Bond of the University of Houston. Professor Bond termed the effects "Paradoxical Pharmacology," based on the divergence of acute versus chronic effects of certain drugs in chronic diseases. For further information, please visit Inverseon's website at http://www.inverseon.com.

Forward-Looking Statement

This press release may contain forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "poten
'/>"/>

SOURCE Inverseon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Landfill mining reduces environmental impact of growing waste
2. Landfill mining reduces environmental impact of growing waste
3. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
4. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
5. Heavier hydrogen on the atomic scale reduces friction
6. Genmab Announces Encouraging Preclinical Data for ofatumumab
7. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
8. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
9. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
10. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
11. Arpida Presents Preclinical Data on AR-2474 at ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire...oday it is acquiring the assets of Hyland Seeds, a...o. The addition of Hyland Seeds will further expan...company anticipates the introduction of SmartStax...olerant Trait Technology in corn in 2012. The tran...
(Date:11/24/2009)... Health care employment grew by 29,...y one to show consistent growth during the U.S. re...remain in trouble, and health systems are coming c... instead of just administrators. , ... employment continued growing in October despite t...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCa...maceutical company focused on developing and comme...ced today that Anthony DiTonno, President and Chie...e 21st Annual Piper Jaffray Health Care Conference...lace Hotel in New York, New York. ,, Mr. DiTon...
(Date:11/24/2009)... The FBI recently approved the Promeg...articipating in or generating DNA records for the ... Madison, WI USA (PRWEB) -- The FBI recently ap...or use by laboratories participating in, or genera...m (NDIS). NDIS currently contains more than seven ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...y Subjects with Decreased Enzyme Activity Appear Y...om Nu Skin,Enterprises Inc. (NYSE: NUS ) presente...International Federation of Societies of Cosmetic ... correlation between levels of a,newly identified ...ce. The,study, conducted at Stanford University, d...
... Incidence of Late Stent Thrombosis Reported in CU... Trials, WASHINGTON and MENLO PARK, Calif., Oct....positive long-term follow-up,data from the CUSTOM ...efficacy of the Custom NX(R) drug eluting stent (D...ry disease. The CUSTOM clinical trials are,prospec...
...JOSE, Calif., Oct. 13 VNUS(R) Medical,Technologie...dical devices,for the minimally invasive treatment...at it plans to report its financial results for th...e close of market on October 29., VNUS plans to h....m. PT,/ 5:00 p.m. ET on October 29. This call wil...
Other Biology Technology:Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 2Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 3Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 2Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 3VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the bare... required to produce a cell that can survive on it...cell, and understand how an entire organism functi...ons that scientists in a partnership between the E...delberg, Germany, and the Centre de Regulacio Genm...
(Date:11/25/2009)...hrelin, a hormone produced in the stomach, may be ...ent of Parkinson,s disease, Yale School of Medicin...ent issue of the Journal of Neuroscience . , Pa...opamine neurons in an area of the midbrain known a...opamine production. Reduced production of dopamin...
(Date:11/25/2009)... Dr. Sarit Larisch, Head of the Cell Death Researc...nt of Biology, has been awarded the prestigious Jo...arch exploring the cause of brain cell damage in P...ch year to scientists in support of innovation and... officially conferred earlier this month at an eve...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Carnitine supplements reverse glucose intolerance in animals 9553 1Carnitine supplements reverse glucose intolerance in animals 9553 2New insights into limb formation 9549 1New insights into limb formation 9549 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 1Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 3
...developed a synthetic wood substitute that may one...nd shrink landfills. , The faux lumber is made fr...in a variety of building materials and perhaps rep...ns of disposable water bottles. , "This is a grea...al need and respect and protect the natural enviro...
...ardiovascular Molecular Imaging , This two-day s... leading-edge research in imaging technology and t...uding imaging of cardiovascular receptors, vascula...pair. , SNM and the International Partnership fo...e meeting devoted to FDA requirements for manufact...
...ls reveal much earlier origins of modern octopuses...ssils. The chances of an octopus corpse surviving ...or to this discovery only a single fossil species ... have legs. , Everyone knows what an octopus is. ...h, the eight arms, suckers, and sack-like body are...
Other Biology News:Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 2Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 3SNM Symposium on Multimodality Cardiovascular Molecular Imaging 2Cretaceous octopus with ink and suckers -- the world's least likely fossils? 2
Mouse Anti-Polo like kinase Monoclonal Antibody, Unconjugated, Clone AZ24 from Abcam
...The dotLab System brings together two mature, well...raction and immobilized capture surfaces. This com...nique for the detection of molecular binding event...otein-specific capture molecules are immobilized o...
Heparin Clotting Assay Kit, HEPTEST from AMERICAN DIAGNOSTICA
Mun I (Mfe I) from Takara Mirus Bio
Biology Products: